439 related articles for article (PubMed ID: 16175613)
1. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine.
Wang HH; Wang DQ
Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
Véniant MM; Zlot CH; Walzem RL; Pierotti V; Driscoll R; Dichek D; Herz J; Young SG
J Clin Invest; 1998 Oct; 102(8):1559-68. PubMed ID: 9788969
[TBL] [Abstract][Full Text] [Related]
3. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol.
Sorci-Thomas M; Wilson MD; Johnson FL; Williams DL; Rudel LL
J Biol Chem; 1989 May; 264(15):9039-45. PubMed ID: 2722816
[TBL] [Abstract][Full Text] [Related]
4. Endurance exercise training reduces gallstone development in mice.
Wilund KR; Feeney LA; Tomayko EJ; Chung HR; Kim K
J Appl Physiol (1985); 2008 Mar; 104(3):761-5. PubMed ID: 18187606
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.
Yu L; Li-Hawkins J; Hammer RE; Berge KE; Horton JD; Cohen JC; Hobbs HH
J Clin Invest; 2002 Sep; 110(5):671-80. PubMed ID: 12208868
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice.
Morales MG; Amigo L; Balboa E; Acuña M; Castro J; Molina H; Miquel JF; Nervi F; Rigotti A; Zanlungo S
Liver Int; 2010 Jul; 30(6):887-97. PubMed ID: 20408952
[TBL] [Abstract][Full Text] [Related]
7. Piperine prevents cholesterol gallstones formation in mice.
Song XY; Xu S; Hu JF; Tang J; Chu SF; Liu H; Han N; Li JW; Zhang DM; Li YT; Chen NH
Eur J Pharmacol; 2015 Mar; 751():112-7. PubMed ID: 25645812
[TBL] [Abstract][Full Text] [Related]
8. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
[No Abstract] [Full Text] [Related]
9. Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis.
Lee EJ; Kim MH; Kim YR; Park JW; Park WJ
Int J Mol Med; 2018 Mar; 41(3):1715-1723. PubMed ID: 29286073
[TBL] [Abstract][Full Text] [Related]
10. LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile.
Hu X; Steffensen KR; Jiang ZY; Parini P; Gustafsson JÅ; Gåfvels M; Eggertsen G
J Intern Med; 2012 Nov; 272(5):452-64. PubMed ID: 22329358
[TBL] [Abstract][Full Text] [Related]
11. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse.
Wang DQ; Tazuma S; Cohen DE; Carey MC
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G494-502. PubMed ID: 12748061
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
Farese RV; Véniant MM; Cham CM; Flynn LM; Pierotti V; Loring JF; Traber M; Ruland S; Stokowski RS; Huszar D; Young SG
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6393-8. PubMed ID: 8692825
[TBL] [Abstract][Full Text] [Related]
13. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited.
Basso F; Freeman LA; Ko C; Joyce C; Amar MJ; Shamburek RD; Tansey T; Thomas F; Wu J; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
J Lipid Res; 2007 Jan; 48(1):114-26. PubMed ID: 17060690
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
Wang HH; Li X; Patel SB; Wang DQ
Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice.
Xie Y; Fung HY; Newberry EP; Kennedy S; Luo J; Crooke RM; Graham MJ; Davidson NO
J Lipid Res; 2014 Mar; 55(3):540-8. PubMed ID: 24474819
[TBL] [Abstract][Full Text] [Related]
16. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
Wang HH; Portincasa P; Mendez-Sanchez N; Uribe M; Wang DQ
Gastroenterology; 2008 Jun; 134(7):2101-10. PubMed ID: 18442485
[TBL] [Abstract][Full Text] [Related]
17. High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice.
Wang DQ; Zhang L; Wang HH
Biochim Biophys Acta; 2005 Mar; 1733(1):90-9. PubMed ID: 15749059
[TBL] [Abstract][Full Text] [Related]
18. Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knock-out and wild-type mice.
Kendrick JS; Chan L; Higgins JA
Biochem J; 2001 Jun; 356(Pt 3):821-7. PubMed ID: 11389690
[TBL] [Abstract][Full Text] [Related]
19. Intestinal SR-BI is upregulated in insulin-resistant states and is associated with overproduction of intestinal apoB48-containing lipoproteins.
Hayashi AA; Webb J; Choi J; Baker C; Lino M; Trigatti B; Trajcevski KE; Hawke TJ; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G326-37. PubMed ID: 21546579
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
Véniant MM; Pierotti V; Newland D; Cham CM; Sanan DA; Walzem RL; Young SG
J Clin Invest; 1997 Jul; 100(1):180-8. PubMed ID: 9202070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
